Diagnostic Performance of Erythropoietin and Erythropoietin Receptors Levels in Children with Attention Deficit Hyperactivity Disorder
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: Attention deficit hyperactivity disorder (ADHD) is a heterogeneous, highly heritable, a common childhood neurobehavioural disorder resulting from complex gene-gene and gene-environment interactions. The erythropoietin (Epo)/erythropoietin receptors (EpoR) system turned out to have additional important functions in nonhematopoietic tissue. In this study, we aimed to investigate the levels of Epo and and EpoR, and also their diagnostic values in children with ADHD. Methods: A total of 70 children were included in the study, 35 drug-naive patients with ADHD (age: 6−12 years; male/female: 20/15) and 35 healthy controls (age: 6−12 years; male/female: 22/13). Serum Epo and EpoR levels was determined using a commercial sandwich enzyme-linked immunosorbent assay kit. Results: The results indicated that the levels of Epo decreased in patients with ADHD compared to control (p ＜ 0.05). On the other hand, EpoR levels increased in these patients (p ＜ 0.05). Furthermore, the ratio of Epo/EpoR was significantly lower in ADHD patients than controls (p ＜ 0.05). Receiver operator characteristic curve analysis showed high diagnostic performance for Epo and EpoR, areas under curve were 0.980 and 1.000, respectively. Conclusion: This is the first report to investigate the association between serum Epo and EpoR levels in ADHD patients. Our results indicated that Epo may play a role in the etiology of ADHD, and Epo therapy may be beneficial in these disorders if given in addition to the routine treatment of children with ADHD. Furthermore, our results reveal possible diagnostic value of Epo and EpoR.
Abstract
Objective: Attention deficit hyperactivity disorder (ADHD) is a heterogeneous, highly heritable, a common childhood neurobehavioural disorder resulting from complex gene-gene and gene-environment interactions. The erythropoietin (Epo)/erythropoietin receptors (EpoR) system turned out to have additional important functions in nonhematopoietic tissue. In this study, we aimed to investigate the levels of Epo and and EpoR, and also their diagnostic values in children with ADHD. Methods: A total of 70 children were included in the study, 35 drug-naive patients with ADHD (age: 6−12 years; male/female: 20/15) and 35 healthy controls (age: 6−12 years; male/female: 22/13). Serum Epo and EpoR levels was determined using a commercial sandwich enzyme-linked immunosorbent assay kit. Results: The results indicated that the levels of Epo decreased in patients with ADHD compared to control (p ＜ 0.05). On the other hand, EpoR levels increased in these patients (p ＜ 0.05). Furthermore, the ratio of Epo/EpoR was significantly lower in ADHD patients than controls (p ＜ 0.05). Receiver operator characteristic curve analysis showed high diagnostic performance for Epo and EpoR, areas under curve were 0.980 and 1.000, respectively. Conclusion: This is the first report to investigate the association between serum Epo and EpoR levels in ADHD patients. Our results indicated that Epo may play a role in the etiology of ADHD, and Epo therapy may be beneficial in these disorders if given in addition to the routine treatment of children with ADHD. Furthermore, our results reveal possible diagnostic value of Epo and EpoR.
참고문헌 (33)
- Biederman J, "Attention-deficit", hyperactivity disorder : a selective overview, 2005, pp.57, 1215~1220
- Polanczyk G, "The worldwide prevalence of ADHD : a systematic review and metaregression analysis", Am J Psychiatry, 164, pp.942~948 (2007)
- Willcutt EG, "The prevalence of DSM-IV attention-deficit", hyper-activity disorder : a meta-analytic review, 2012, pp.9, 490~499
- Davies W, "Sex differences in attention deficit hyperactivity disorder : candidate genetic and endocrine mechanisms", Front Neuroendocrinol, 35, pp.331~346 (2014)
- Klein RG, "Clinical and functional outcome of childhood attention-deficit", hyperactivity disorder 33 years later, 2012, pp.69, 1295~1303
- Satterfield JH, "A 30-year prospective follow-up study of hyperactive boys with conduct problems : adult criminality", J Am Acad Child Adolesc Psychiatry, 46, pp.601~610 (2007)
- American Psychiatric Association, "Diagnostic and statistical manual of mental disorders: DSM-5" (2013), American Psychiatric Publishing
- Gallo EF, "Moving towards causality in attention-deficit hyperactivity disorder : overview of neural and genetic mechanisms", Lancet Psychiatry, 3, pp.555~567 (2016)
- Polanczyk GV, "Attention deficit disorder", hyperactivity: a scientific overview, 2012, pp.67, 1125~1126
- Quintero J, "Advances in attention deficit hyperactivity disorder. What does neuroimaging provide us with?", Actas Esp Psiquiatr, 37, pp.352~358 (2009)
- McPherson RJ, "Recent trends in erythropoietin-mediated neuroprotection", Int J Dev Neurosci, 26, pp.103~111 (2008)
- Meng SZ, "Dopamine transporter and nitric oxide synthase in hypoxic-ischemic brain", Pediatr Neurol, 22, pp.115~121 (2000)
- Kurutas EB, "The importance of antioxidants which play the role in cellular response against oxidative", nitrosative stress : current state, 2016, pp.15, 71~
- Howren MB, "Associations of depression with C-reactive protein, IL-1, and IL-6 : a meta-analysis", Psychosom Med, 71, pp.171~186 (2009)
- Ebru Fındıklı, "The Diagnostic Value of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Drug Naïve, First Episode, Non-Smoker Generalized Anxiety Disorder Patients", Clinical Psychopharmacology and Neuroscience, 16(1), pp.88~94 (2018), 대한정신약물학회[DOI]
- Kaufman J, "Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version(K-SADS-PL) : initial reliability and validity data", J Am Acad Child Adolesc Psychiatry, 36, pp.980~988 (1997)
- "Turk J Child Adolesc Ment Health", 2004, 109~116
- Conners CK, "Conners’ rating scales-revised: user’s manual" (1997), Multi-Health Systems
- Goyette CH, "Normative data on revised Conners parent and teacher rating scales", J Abnorm Child Psychol, 6, pp.221~236 (1978)
- "Turk Psikiyatri Derg", 2007, 48~58
- Şener Ş, "Conners’ teacher rating scale Turkish version-I", J Child Youth Ment Health, 2, pp.131~141 (1995)
- Guney E, "Attention deficit hyperactivity disorder and oxidative stress : a short term follow up study", Psychiatry Res, 229, pp.310~317 (2015)
- Bulut M, "Lipid peroxidation markers in adult attention deficit hyperactivity disorder : new findings for oxidative stress", Psychiatry Res, 209, pp.638~642 (2013)
- Oztop D, "Oxidative stress in children with attention deficit hyperactivity disorder", Clin Biochem, 45, pp.745~748 (2012)
- Tsai PT, "A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery", J Neurosci, 26, pp.1269~1274 (2006)
- Savino R, "A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent", Cell Death Differ, 11(Suppl 1), pp.S2~S4 (2004)
- Tong W, "Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways", Blood, 105, pp.4604~4612 (2005)
- Sirén AL, "Erythropoietin and erythropoietin receptor in human ischemic", hypoxic brain, 2001, pp.101, 271~276
- Campana WM, "Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury", Eur J Neurosci, 18, pp.1497~1506 (2003)
- Keswani SC, "A novel endogenous erythropoietin mediated pathway prevents axonal degeneration", Ann Neurol, 56, pp.815~826 (2004)
- Okutan O, "Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats", J Clin Neurosci, 14, pp.364~368 (2007)
- Taylor R, "Interpretation of the correlation coefficient : a basic review", J Diagn Med Sonogr, 6, pp.35~39 (1990)
- Willcutt EG, "Validity of the executive function theory of attention-deficit", hyperactivity disorder : a meta-analytic review, 2005, pp.57, 1336~1346